Dr. Madhukar Pai
GET UPDATES FROM Dr. Madhukar Pai
 
Prof Madhukar Pai, MD, PhD is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB Centre.

Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at UC Berkeley, and a postdoctoral fellowship at the UCSF. Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB committee of WHO, Geneva; Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance, New York. He has previously served on the Coordinating Board of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, PLoS ONE, International Journal of TB and Lung Disease, among others. Madhu’s research is mainly focused on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 200 peer-reviewed publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, and Haile T. Debas Prize. He is a member of the Royal Society of Canada.

His book on tuberculosis can be accessed free at: www.letstalktb.org

Entries by Dr. Madhukar Pai

Bridging The Gap Between Tuberculosis Innovation And Access

(0) Comments | Posted May 2, 2017 | 9:54 AM

Never bring a knife to a gunfight. And yet, the global tuberculosis (TB) community has been doing precisely that for decades -- fighting a protracted battle with antiquated, inefficient tools, including an insensitive diagnostic (i.e. sputum microscopy), a low-efficacy vaccine (i.e. BCG), and drug regimens that have hardly...

Read Post

Creating A Community To Advance Global Health Diagnostics

(0) Comments | Posted February 22, 2017 | 3:44 PM

By Madhukar Pai & Rebecca Weintraub

Despite the critical importance of diagnosis, diagnostic testing and laboratory capacity receive much less attention than vaccines and drugs in the global health arena. There are many tropical diseases for which good diagnostics do not exist, and there are other conditions for...

Read Post

'Cascade Of Care' Can Help India Plug Gaps In TB Treatment

(0) Comments | Posted October 26, 2016 | 1:32 PM

india tuberculosis
TB patients in Patel Chest Hospital on May 29, 2013 in New Delhi, India. (Photo: Ramesh Pathania/Mint via Getty Images)

By Ramnath Subbaraman & Madhukar Pai

Tuberculosis (TB) is the leading infectious cause of death globally. In 2015, WHO estimated that...

Read Post

New Numbers On Tuberculosis Burden Must Galvanize India To Act

(0) Comments | Posted October 17, 2016 | 5:19 PM

Last week, WHO released its 2016 Global TB Report. The news, unfortunately, is not good. The report shows that the TB burden is actually higher than previously estimated, mainly because of new data from India. In 2015, there were an estimated 10.4 million new TB cases worldwide. Six...

Read Post

Predatory Conferences Undermine Science And Scam Academics

(4) Comments | Posted October 13, 2016 | 5:01 PM

In our recent post, we wrote about predatory open access journals and the threat they pose to research and medical practice. Predatory OA journals are run by entrepreneurs (con artists, in our opinion) that have little or no scientific credibility, but publish "journals" which essentially print everything that...

Read Post

What Are Predatory Open Access Journals And Why Should We Worry?

(5) Comments | Posted October 4, 2016 | 9:14 AM

Last week, CTV News and Toronto Star broke the news about two of Canada's well known publishing houses for medical journals (Pulsus Group and Andrew John Publishing) have been bought by OMICS International, a predatory publisher based out of India....

Read Post

Drug-Resistant TB Should Figure Prominently In The Global AMR Response

(0) Comments | Posted September 20, 2016 | 3:09 PM

On 21 September 2016, the President of the UN General Assembly will convene a one-day high-level meeting at the UN Headquarters in New York on "Antimicrobial Resistance" (AMR) with the participation of Member States, NGOs, civil society, the private sector and academic institutions.

This is timely and...

Read Post

Canada Is Leading The Fight To End AIDS, TB And Malaria For Good

(1) Comments | Posted September 16, 2016 | 9:52 AM

As Montreal gears up to host the biggest leaders in global health, it is our hope that Canada will go well beyond provision of international aid, and find a way to harness the abundant scientific talent in Canada. Doing so will not only amplify the financial contributions by Canadians, but...

Read Post